SEC Form 4 · accession 0001055726-17-000008
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jong Joseph Kim
Officer — Chief Executive Officer · Director
Period of report
Mar 9, 2017
Accepted (ET)
Mar 13, 2017 · 5:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 9, 2017 | M | 57,334 | — | A | 2,021,944 | D | |
| Common Stock | Mar 9, 2017 | F | 17,787 | $6.61 | D | 2,004,157 | D | |
| Common StockF2 | Mar 10, 2017 | M | 139,745 | — | A | 2,143,902 | D | |
| Common Stock | Mar 10, 2017 | F | 52,605 | $6.68 | D | 2,091,297 | D | |
| Common Stock | holding | — | — | — | 1,750,000 | I | By Family Limited Partnership | |
| Common Stock | holding | — | — | — | 33,563 | I | By Daughter: EK | |
| Common Stock | holding | — | — | — | 33,775 | I | By Son: JK1 | |
| Common Stock | holding | — | — | — | 5,975 | I | By Spouse | |
| Common Stock | holding | — | — | — | 33,533 | I | By Son: JK2 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1 | — | Mar 9, 2017 | M | 57,334 | D | — | — | Common Stock | 57,334 | 114,666 | D |
| Common Stock OptionF3 | $6.68 | Mar 10, 2017 | A | 43,150 | A | Mar 10, 2017 | Mar 10, 2027 | Common Stock | 43,150 | 43,150 | D |
| Restricted Stock UnitF4 | — | Mar 10, 2017 | A | 317,100 | A | — | — | Common Stock | 317,100 | 317,100 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 172,000 restricted stock units is as follows: 57,334 vested on March 9, 2017; 57,333 shares will vest on March 9, 2018; 57,333 shares will vest on March 9, 2019. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.
- F2These restricted stock units vested 100% on the March 10, 2017 grant date.
- F3The vesting schedule for the 43,150 options is as follows: 10,787 shares vested on March 10, 2017; 10,788 shares will vest on March 10, 2018; 10,787 shares will vest on March 10, 2019; 10,788 shares will vest on March 10, 2020.
- F4Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares will vest on March 10, 2018; 105,700 shares will vest on March 10, 2019; 105,700 shares will vest on March 10, 2020. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.